R. Alsaggaf

First name

R.

Last name

Alsaggaf

Liu, Z., Alsaggaf, R., McGlynn, K. A., Anderson, L. A., Tsai, H. T., Zhu, B., et al. (2018). Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Gut. http://doi.org/10.1136/gutjnl-2018-317504

View

Wang, Y., Pfeiffer, R. M., Alsaggaf, R., Meeraus, W., Gage, J. C., Anderson, L. A., et al. (2018). Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. Int J Cancer. http://doi.org/10.1002/ijc.31143

View

Alsaggaf, R., St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Wagner, K. R., et al. (2018). Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. JNCI Cancer Spectr. http://doi.org/10.1093/jncics/pky052

View

Alsaggaf, R., Pfeiffer, R. M., Wang, Y., St George, D. M. M., Zhan, M., Wagner, K. R., et al. (2019). Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I. Int J Cancer. http://doi.org/10.1002/ijc.32801

View

Alsaggaf, R., St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., et al. (2019). Benign tumors in myotonic dystrophy type I target disease-related cancer sites. Ann Clin Transl Neurol. http://doi.org/10.1002/acn3.50856

View